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Introduction was found, but not reproduced. Later tests showed a
positive screening for lupus anticoagulant. He was
Patients with aortic aneurysms are selected for aortic successfully treated with warfarin for 3 months.
stent-grafting depending mainly on anatomical suit- Six months after this incident, he was treated with
ability. Patients are treated with conventional open stent-grafting for his abdominal aortic aneurysm, with
surgery if the aneurysmal neck is too wide or too short, a Vanguard 24/12 stent-graft and additional 12–14 mm
if it is considerably tapered or if there is substantial covered Symphony stents in both iliac arteries.
thrombosis or calcification in the neck. Also iliac ana- The procedure was uneventful, and the 3-month
tomical contraindications may result in open surgery. follow-up CT scans showed perfect positioning of the
However, other patient factors should probably be graft with no endoleak. However, 4 months after the
considered when deciding whether a patient is suitable procedure, he was admitted to the hospital with rest
for stent-grafting, as shown by this case report. pain in his right foot and an ankle/brachial pressure
index (ABPI) of 0.5. Angiography showed thrombotic
masses in the iliac part of the right leg of the prosthesis
and peripheral embolisation (Fig. 1). There were noCase Report
signs of infection either on CT or clinically, and his
CRP was low. The rest pain disappeared after anti-A 78-year-old man had an ultrasound in the in-
coagulation with warfarin and low dose aspirin, andvestigation of abdominal pains and an abdominal
he had an ABPI of 0.9 when he was discharged. Theaortic aneurysm of 50 mm diameter was detected.
aspirin had to be discontinued after a short while dueThe patient was otherwise fit and had never been
to dyspepsia.hospitalised. He begged to be treated, since he was
Although control angiograms indicated a possibleafraid of aneurysm rupture.
angulation in the graft body, a Triplex scan could notHe was found anatomically suitable for stent-graft-
verify flow increase or structural changes in that area.ing. In the meantime he was admitted to the De-
Only 2 months after this, he was admitted againpartment of Medicine, and a deep vein thrombosis of
with rest pain in the right leg. This time the thrombotichis left femoral vein was found. He also had distal
material in the right leg of the graft was more sub-lipodermatosclerosis in the same leg suggestive of
stantial, and thrombolysis with r-tPA was performedlongstanding venous problems. A CT scan of the lungs
to prevent further embolisation (Fig. 2). A PTA of theshowed a small infarction, corresponding to a previous
right popliteal artery was also performed, and he wassmall lung embolism. A low level of protein C (65%)
discharged well on warfarin. Control duplex scanningwas detected, and an activated protein C resistance
1 month after this showed no rest thrombosis and he
felt well and walked without restriction.∗ Please address all correspondence to: A. K. Lindahl, Oslo Centre
for Vascular Surgery, Aker University Hospital, 0514 Oslo, Norway. However, after another month, a repetition of the
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Discussion
Thrombophilia is known mostly to predict venous
thromboembolism. Lupus anticoagulant has been con-
sidered the abnormality most frequently detected in
patients with peripheral occlusive disease.1,2 A few
case reports have associated changes in the coagulation
inhibitor protein S with arterial thrombi. The most
frequent factor predisposing for thrombosis, activated
protein C resistance, has been even more prevalent
in patients with peripheral arterial disease and graft
occlusion than in controls.3–5 Changes in more than
one of these parameters indicate a greater risk for
venous thrombosis, possibly in a potentiating rather
than additive way.3 It is still unknown whether one
or more of these factors influence the risk for arterial
thrombosis. It is, however, likely that a heavy throm-
bophilia risk burden would increase the risk for arterial
thrombosis as well, as in this patient who had both
reduced levels of protein C and a positive lupus anti-
coagulant.
Aortic stent-grafting or conventional aorto-bi-
femoral grafting has not been associated with a par-
ticular risk for graft thrombosis unless there are signs
of infection. In this patient, there were no signs of
infection and there was seemingly nothing in the
anatomical appearances of his native arteries or the
positioning of the graft that might predispose for
thrombotic events. The only likely explanation for the
occurrence of his thrombotic events was his throm-
bophilia. It is reasonable to believe that there mightFig. 1. Thrombotic masses in the right leg of the graft.
also be some slight changes in the graft wall, or the
area where the extention iliac graft was attached, that
predisposed for thrombosis in this particular leg of theprevious incidents occurred. He was treated with
graft. Although the angiograms could be interpretedthrombolysis again, and two small peripheral thrombi
as showing an angulation in the graft body in onewere aspirated. It was noted that it was difficult to
projection, triplex scanning could not verify structuralcontrol his warfarin treatment. On his control chart
or flow changes in that area. The fact that he had athe seemed to be in the treatment range for only short
least two independent risk factors for thrombosisperiods of time, but had mostly been in the INR range
would make him more sensitive than other patientsof 2.0–2.1. Although a considerable effort was put into
to small precipitating structural changes. However,controlling his INR, he was admitted with thrombosis
he might have had thrombotic events even with aof his right femoral artery for the fourth time after
conventional aortic graft, and we do not have anyanother 3 months with an INR of 2.0. This time he
evidence that the Vanguard graft is more likely towas again treated with thrombolysis with r-tPA, and
precipitate a thrombotic event than any other graft,with additional peripheral thrombus aspiration. Con-
conventional or stent-graft. Why his INR was so dif-trol angiography showed no remaining thrombotic
ficult to keep in the therapeutic range is still unknown.material, and he was free of symptoms. A control
It is known that some people have enzymatic changesroutine with INR measurements twice a week was
or increased clearance that make them relatively in-instituted, in addition to thorough oral and written
sensitive to warfarin.6,7 Also, a relative warfarin re-information. After that his INR has been in the rel-
sistance could occur due to interaction with otheratively intense treatment range of 3–3.5 and no more
drugs, reduced absorption of warfarin or a particularlythrombosis has occurred in the 9 months that have
passed since the last incident. high vitamin K uptake, and this could explain the
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Fig. 2. Distal embolisation (a) before thrombolysis, (b) after thrombolysis with r-tPA, (c) after thrombolysis and PTA.
difficulties in keeping the INR at a high enough anti-
coagulant level. The reason for his continuing low INT
levels has not been identified, but his INR levels are
now adequate with the new, intensified control routine.
We conclude from this case report that throm-
bophilia may be considered a relative contraindication
for aortic stent-grafting. Open surgery may in this
patient have represented an even greater thrombotic
risk with the possibility of a life-threatening lung
embolism. In retrospect, this particular patient would
probably have been better treated conservatively and
followed with ultrasound for further dilation of his
aneurysm, with suitable psychological support.
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